Chronic Cerebrovascular Insufficiency Support Protocol
Primary Stack
Core supplements with strongest evidenceImproves cerebral blood flow; studied extensively for cognitive symptoms from vascular insufficiency
Improves endothelial function and blood flow; anti-inflammatory effects support vascular health
Supporting Stack
Additional supplements for enhanced resultsSupports brain cell membrane repair and neurotransmitter synthesis; studied for vascular cognitive impairment
Supporting Studies (1)
Improves cerebral blood flow and metabolism; derived from periwinkle; used in Europe for cognitive symptoms
Supporting Studies (1)
Antioxidant; supports cellular energy; may improve endothelial function
Supporting Studies (1)
Antioxidant that protects cell membranes; may help with vascular-related cognitive decline
Supporting Studies (1)
B12, B6, and folate reduce homocysteine; elevated homocysteine is a vascular risk factor
Supporting Studies (1)
Supports blood vessel relaxation; low magnesium associated with increased stroke risk
Supporting Studies (1)
Polyphenol that may improve endothelial function and cerebral blood flow
Supporting Studies (1)
How This Protocol Works
Simple Explanation
Chronic cerebrovascular insufficiency refers to reduced blood flow to the brain, typically from atherosclerosis (hardening of the arteries) affecting blood vessels that supply the brain. This can cause symptoms like dizziness, memory problems, difficulty concentrating, headaches, and in severe cases, can lead to stroke or vascular dementia.
CRITICAL: Reduced blood flow to the brain is a serious condition that requires medical evaluation. This protocol is SUPPORTIVE and does not replace medical treatment.
MEDICAL EVALUATION AND TREATMENT:
LIFESTYLE MODIFICATIONS:
* Ginkgo Biloba is the most studied supplement for cerebral blood flow. It improves blood circulation to the brain and has been used in Europe for decades for cognitive symptoms related to vascular insufficiency.
* Omega-3 Fatty Acids support blood vessel health and reduce inflammation.
* Citicoline supports brain cell membrane integrity and may help with cognitive symptoms.
* B Vitamins (B12, B6, folate) reduce homocysteine, an amino acid associated with increased stroke risk.
Expected timeline: Supplements may provide gradual improvement over 3-6 months. Acute symptoms like sudden dizziness, vision changes, weakness, or speech problems require immediate medical attention as they may indicate stroke.
Clinical Perspective
Chronic Cerebrovascular Insufficiency: Reduced cerebral perfusion from atherosclerotic disease of carotid, vertebral, or intracranial arteries. Presentation: cognitive impairment (vascular cognitive impairment), dizziness/vertigo, headaches, visual disturbances, TIAs. Related conditions: carotid stenosis, vertebrobasilar insufficiency, small vessel disease (white matter lesions). Diagnosis: carotid duplex ultrasound, CTA/MRA, transcranial Doppler.
CRITICAL: Stroke is major risk. Rule out critical stenosis requiring intervention (CEA/stenting for symptomatic >50% or asymptomatic >70% carotid stenosis). Secondary prevention: antiplatelet, statin, BP control, lifestyle. Supplements are ADJUNCTIVE to guideline-directed medical therapy and risk factor modification.
* Ginkgo Biloba (B-grade): Cerebral blood flow; cognition. Cochrane: (PMID: 24679190). Meta-analysis: (PMID: 28482006). 120-240mg EGb 761 daily. Best evidence; used extensively in Europe.
* Omega-3 Fatty Acids (B-grade): Vascular health; anti-inflammatory. Systematic review: (PMID: 27840029). 2-4g EPA+DHA daily.
* Citicoline (B-grade): Membrane repair; neurotransmitters. Systematic review: (PMID: 26096827). 500-2000mg daily.
* Vinpocetine (B-grade): Cerebral blood flow. Systematic review: (PMID: 14583256). 10-30mg daily. Used in Europe.
* Coenzyme Q10 (C-grade): Antioxidant; endothelial function. Review: (PMID: 26597398). 100-200mg daily.
* Vitamin E (C-grade): Antioxidant. Review: (PMID: 27918887). 400-800 IU daily.
* B-Complex (B-grade): Homocysteine reduction. Systematic review: (PMID: 27450775). Methylated forms daily. Check B12 and homocysteine levels.
* Magnesium (C-grade): Vascular relaxation. Review: (PMID: 28150472). 300-400mg daily.
* Resveratrol (C-grade): Endothelial function. Review: (PMID: 25048990). 100-500mg daily.
Assessment targets: Carotid imaging, cognitive testing (MoCA, MMSE), blood pressure, lipid panel, HbA1c, homocysteine, inflammatory markers.
Protocol notes: Risk factor control: most important - BP <130/80, LDL goals per guidelines, HbA1c <7%, smoking cessation. Antiplatelet therapy: aspirin or clopidogrel; dual antiplatelet after stent. Statins: reduce stroke risk independent of cholesterol level; plaque stabilization. Carotid stenosis: symptomatic >50% or asymptomatic >70% may benefit from CEA or stenting - vascular surgery/interventional referral. Small vessel disease: white matter hyperintensities on MRI; aggressive risk factor control; no specific treatment proven. Falls: dizziness increases fall risk; home safety, gait aids. Driving: consider evaluation if significant cognitive impairment. Ginkgo interactions: may increase bleeding with anticoagulants/antiplatelets - use cautiously, monitor. Orthostatic hypotension: can mimic or worsen cerebrovascular insufficiency; check BP lying/standing. Cardiac evaluation: often coexisting CAD; consider cardiac workup.